Despite the recent surge of COVID-19 cases, multiple US insurers are scaling back telehealth coverage. One recent article details these changes to health plans, which includes expiration dates for terminating or reducing expanded telehealth coverage to pre-COVID levels and resumption of cost sharing.
At TTi, we advised that this coverage expansion was only temporary and we helped prepare medtech developers to prove their value and validity to the marketplace using real world evidence (RWE).
We hope you’ve been following our insights and recommendations for maximal and sustained adoption and coverage of your technology – especially digital/remote tools. It’s not too late to prove your value and validity to the evolving marketplace!
Secure your payer coverage, coding, and reimbursement by generating real world evidence to demonstrate the value of your technology in terms of:
- Reduced costs
- Improved outcomes
- Enhanced patient, provider, and caregiver satisfaction
By utilizing RWE, we recently helped one client rapidly expand health insurance coverage of their technology to more than 50 million lives. Interested in learning how we can help you do the same? Contact us for support.